News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,406 Results
Type
Article (2597)
Company Profile (45)
Press Release (37763)
Multimedia
Podcasts (9)
Webinars (2)
Section
Business (14296)
Career Advice (85)
Deals (2127)
Drug Delivery (9)
Drug Development (4160)
Employer Resources (10)
FDA (448)
Job Trends (788)
News (20428)
Policy (1071)
Tag
Academia (147)
Allergies (7)
Alliances (3518)
ALS (6)
Alzheimer's disease (59)
Antibody-drug conjugate (ADC) (27)
Approvals (451)
Artificial intelligence (31)
Autoimmune disease (9)
Automation (2)
Bankruptcy (12)
Best Places to Work (481)
BIOSECURE Act (2)
Biosimilars (16)
Biotechnology (29)
Bladder cancer (8)
Brain cancer (7)
Breast cancer (44)
Cancer (326)
Cardiovascular disease (10)
Career advice (72)
Career pathing (1)
CAR-T (33)
CDC (1)
Cell therapy (84)
Cervical cancer (2)
Clinical research (3450)
Collaboration (202)
Company closure (2)
Compensation (105)
COVID-19 (185)
CRISPR (11)
C-suite (114)
Cystic fibrosis (7)
Data (420)
Denatured (6)
Depression (11)
Diabetes (18)
Diagnostics (525)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (36)
Drug pricing (11)
Duchenne muscular dystrophy (42)
Earnings (4520)
Editorial (5)
Employer branding (1)
Employer resources (8)
Events (6427)
Executive appointments (135)
FDA (594)
Friedreich's ataxia (4)
Frontotemporal dementia (1)
Funding (168)
Gene editing (32)
Generative AI (1)
Gene therapy (56)
GLP-1 (64)
Government (159)
Guidances (24)
Healthcare (713)
HIV (2)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (35)
Immuno-oncology (14)
Indications (4)
Infectious disease (197)
Inflammatory bowel disease (17)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (25)
Interviews (9)
IPO (1009)
IRA (7)
Job creations (294)
Job search strategy (66)
JPM (4)
Kidney cancer (6)
Labor market (11)
Layoffs (52)
Leadership (3)
Legal (225)
Liver cancer (6)
Longevity (1)
Lung cancer (28)
Lymphoma (12)
Machine learning (3)
Management (4)
Manufacturing (52)
MASH (14)
Medical device (315)
Medtech (316)
Mergers & acquisitions (1235)
Metabolic disorders (73)
Multiple sclerosis (23)
Neurodegenerative disease (27)
Neuropsychiatric disorders (10)
Neuroscience (165)
NextGen: Class of 2026 (353)
Non-profit (157)
Now hiring (11)
Obesity (33)
Opinion (19)
Ovarian cancer (18)
Pain (24)
Pancreatic cancer (21)
Parkinson's disease (11)
Partnered (4)
Patents (53)
Patient recruitment (25)
Peanut (1)
People (5937)
Pharmaceutical (5)
Phase 1 (1476)
Phase 2 (1707)
Phase 3 (917)
Pipeline (399)
Policy (16)
Postmarket research (34)
Preclinical (641)
Press Release (2)
Prostate cancer (7)
Psychedelics (3)
Radiopharmaceuticals (14)
Rare diseases (62)
Real estate (428)
Recruiting (5)
Regulatory (921)
Reports (7)
Research institute (153)
Resumes & cover letters (10)
Rett syndrome (1)
RNA editing (5)
RSV (1)
Schizophrenia (16)
Series A (46)
Series B (21)
Service/supplier (2)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (499)
Stomach cancer (2)
Supply chain (4)
Tariffs (2)
The Weekly (3)
Vaccines (53)
Venture capital (15)
Weight loss (21)
Women's health (10)
Worklife (1)
Date
Today (14)
Last 7 days (56)
Last 30 days (166)
Last 365 days (2436)
2026 (241)
2025 (2440)
2024 (2616)
2023 (2868)
2022 (3765)
2021 (4064)
2020 (3520)
2019 (2084)
2018 (1564)
2017 (1805)
2016 (1637)
2015 (1844)
2014 (1378)
2013 (1200)
2012 (1416)
2011 (1345)
2010 (1201)
Location
Africa (44)
Alabama (3)
Arizona (18)
Asia (1954)
Australia (308)
California (1608)
Canada (246)
China (81)
Colorado (55)
Connecticut (16)
Delaware (5)
Europe (4044)
Florida (65)
Georgia (11)
Hawaii (2)
Idaho (3)
Illinois (21)
India (3)
Indiana (60)
Japan (17)
Kansas (14)
Kentucky (1)
Maryland (48)
Massachusetts (577)
Michigan (14)
Minnesota (22)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (137)
New York (81)
North Carolina (132)
Northern California (785)
Ohio (44)
Oklahoma (2)
Oregon (6)
Pennsylvania (113)
Puerto Rico (1)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (654)
Tennessee (4)
Texas (153)
United States (3230)
Utah (5)
Virginia (11)
Washington D.C. (3)
Washington State (95)
West Virginia (1)
Wisconsin (13)
40,406 Results for "prometheus biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Merck Completes Acquisition of Prometheus Biosciences, Inc.
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the Prometheus Biosciences, Inc. (“Prometheus”) (NASDAQ: RXDX) acquisition.
June 16, 2023
·
6 min read
Deals
Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.
Merck, known as MSD outside the United States and Canada, and Prometheus Biosciences, Inc. announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary, has agreed to acquire Prometheus for $200.00 per share in cash for a total equity value of approximately $10.8 billion.
April 16, 2023
·
12 min read
Biotech Beach
Prometheus Laboratories Announces New Health Plan Agreements to Provide Precision-Guided Testing Services
Prometheus Laboratories Inc. announced the execution of provider agreements with three large regional health plans to facilitate access to PredictrPK®, precision-guided biologic testing, and other Prometheus testing services to the participating health plans and their respective members.
May 9, 2024
·
2 min read
Biotech Beach
Prometheus Biosciences to Participate at November 2022 Healthcare Conferences
Prometheus Biosciences, Inc. announced that management will conduct fireside chats at the following healthcare conferences.
November 1, 2022
·
2 min read
Biotech Beach
Prometheus Biosciences to Present at the SVB Securities Global Biopharma Conference
Prometheus Biosciences, Inc. (Nasdaq: RXDX) today announced that management will conduct a fireside chat at the SVB Securities Global Biopharma Conference on February 14, 2023 at 12:00 PM ET.
February 9, 2023
·
1 min read
Press Releases
Change in Number of Shares and Votes in Alligator Bioscience AB
February 1, 2026
·
1 min read
Press Releases
Waters Completes Combination with BD’s Biosciences & Diagnostic Solutions Businesses
February 10, 2026
·
6 min read
Press Releases
Imbed Biosciences Secures Strategic Investment from BioLab Holdings
February 4, 2026
·
2 min read
Press Releases
Invitation to Alligator Bioscience’s Earnings Call on 12 February 2026
February 5, 2026
·
1 min read
Business
Prometheus Biosciences Reports First Quarter 2023 Financial Results and Highlights Recent Corporate Progress
Prometheus Biosciences, Inc., a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutics for the treatment of immune-mediated diseases, reported financial results for the quarter ended March 31, 2023.
May 9, 2023
·
9 min read
1 of 4,041
Next
